| Eric Edward Bialczak, DPT | |
|
429 Post Rd E, Westport, CT 06880-4432 | |
| (203) 429-4725 | |
| Not Available |
| Full Name | Eric Edward Bialczak |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 429 Post Rd E, Westport, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437766516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 046014 (New York) | Secondary |
| 225100000X | Physical Therapist | 12871 (Connecticut) | Primary |
| Provider Name | Orthopaedic & Neurosurgery Specialists, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033318720 PECOS PAC ID: 5294628947 Enrollment ID: O20170828001424 |
News Archive
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the company received verbal notice on Friday, September 3, 2010 from the U.S. Food and Drug Administration (FDA) that the IDX184 and IDX320 programs have been placed on clinical hold.
Late last month, before President Joe Biden took office and proposed his pandemic relief plan, Congress passed a nearly 5,600-page legislative package that provided some pandemic relief along with its more general allocations to fund the government in 2021.
Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy.
The placenta has an essential and highly complex task: it must ensure the exchange of important substances between the mother and her unborn child, whilst simultaneously blocking other substances from passing through.
It can be a helpless and heartbreaking situation for families as they try to confront a family member with an eating disorder. What they may not know is that there's a society on the Internet that is dedicated to thwarting any recovery from this dangerous and possibly fatal behavior.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Edward Bialczak, DPT 565 Hillside Blvd, New Hyde Park, NY 11040-2911 Ph: (516) 304-8319 | Eric Edward Bialczak, DPT 429 Post Rd E, Westport, CT 06880-4432 Ph: (203) 429-4725 |
News Archive
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the company received verbal notice on Friday, September 3, 2010 from the U.S. Food and Drug Administration (FDA) that the IDX184 and IDX320 programs have been placed on clinical hold.
Late last month, before President Joe Biden took office and proposed his pandemic relief plan, Congress passed a nearly 5,600-page legislative package that provided some pandemic relief along with its more general allocations to fund the government in 2021.
Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy.
The placenta has an essential and highly complex task: it must ensure the exchange of important substances between the mother and her unborn child, whilst simultaneously blocking other substances from passing through.
It can be a helpless and heartbreaking situation for families as they try to confront a family member with an eating disorder. What they may not know is that there's a society on the Internet that is dedicated to thwarting any recovery from this dangerous and possibly fatal behavior.
› Verified 2 days ago
Performance Health Care Management Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 333 Post Rd W, Westport, CT 06880 Phone: 203-422-0679 Fax: 203-422-0931 | |
A Different Approach - Pt For Women Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Franklin St, Suite 103, Westport, CT 06880 Phone: 203-227-8229 Fax: 203-583-3958 | |
Nicholas Giampetruzzi, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 728 Post Rd E, Westport, CT 06880 Phone: 203-341-0488 Fax: 203-227-8809 | |
Valerie Friedman, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 728 Post Rd E, Westport, CT 06880 Phone: 203-341-0488 | |
Andrea Myers, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 Crescent Rd, Westport, CT 06880 Phone: 203-227-5431 | |
Professional Therapy Contracting Services Of Ct, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 329 Riverside Ave, Westport, CT 06880 Phone: 203-557-6477 Fax: 203-557-6481 | |
Joseph A Cristino, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 728 Post Rd E, Westport, CT 06880 Phone: 203-341-0488 Fax: 203-227-8809 |